Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +48.17%
#3 Velvet Velvet +37.34%
#4 Black Phoenix Black Phoenix +34.06%
#5 Akedo Akedo +29.10%
#6 Cross Cross +27.01%
#7 Cap Cap +18.79%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.46%
#9 QANplatform QANplatform +14.35%
#10 Bitway Bitway +13.02%
Coin of the day
Glidr Glidr
Settings
Language
ENGLISH
Currency
USD
Theme
Vencanna Ventures Inc. Vencanna Ventures Inc.

Vencanna Ventures Inc.

VENI
Rank in Stocks #38761
Vencanna Ventures Inc. primarily finances burgeoning cannabis projects around... Vencanna Ventures Inc. primarily finances burgeoning cannabis projects around the world. The enterprise was established on October 4, 1989, and its main operations are based in Calgary, Canada.
Share Price
$0.00366968
Last synced: 2026-07-31
Market Cap
$817.04K
Change (1 day)
0.00%
Change (1 year)
1.38%
Country
CA
Trade Vencanna Ventures Inc. (VENI)

Category

Healthcare
Revenue for Vencanna Ventures Inc. (VENI)
Revenue in Aug 2026 TTM: 0
According to Vencanna Ventures Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Vencanna Ventures Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN